Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases.
about
Retinal vein occlusion: pathophysiology and treatment optionsComplications of Macular PeelingEvaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion.Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion.Arteriovenous sheathotomy for persistent macular edema in branch retinal vein occlusionBranch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalitiesSCORE Study report 3: study design and baseline characteristicsEvaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion.Pars plana vitrectomy combined with focal endolaser photocoagulation for idiopathic macular telangiectasia.Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusionBranch retinal vein occlusion: treatment modalities: an update of the literature.Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusionPractical management of retinal vein occlusions.Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion.Secondary paracentral retinal holes following internal limiting membrane removalPars Plana Vitrectomy Combined with Internal Limiting Membrane Peeling to Treat Persistent Macular Edema after Anti-Vascular Endothelial Growth Factor Treatment in Cases of Ischemic Central Retinal Vein Occlusion.Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema.Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion.Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments.Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab.Optical coherence tomography parameters predictive of visual outcome after anti-VEGF therapy for retinal vein occlusion.Edaravone (MCI-186) is effective as a free radical scavenger following arteriovenous sheathotomy for treatment of macular oedema associated with branch retinal vein occlusion.Management of retinal vein occlusion--consensus document.Inflammation and macular oedema after pars plana vitrectomy.Surgical treatment for macular edema.Histopathologic and electron microscopic features of internal limiting membranes in maculopathies of various etiologiesA comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.SCORE2 Report 2: Study Design and Baseline Characteristics.Retinal vascular disease in hypertension. Risk factor modification optimizes vision outcomes.Post-treatment change in the localization of recurrent or persistent macular edema secondary to branch retinal vein occlusion.
P2860
Q24596993-06289C21-84DD-444B-8DFE-04A804E3213AQ26783400-18C3CC9E-1A03-4C83-B78F-EA9AED89D707Q30455839-B5496D7F-D89A-4F74-A017-15F6A70CFD28Q33261980-B078B36E-BFE0-4A93-9836-88BE7DCF004EQ33273892-C0B6FFDF-272E-4838-AB26-7B9AEADE8EC3Q33320830-A8333BFF-8BE6-4A59-B229-5A7C2EC37154Q33484531-4194AF8C-B404-4343-BE5E-90FDC3198576Q33607767-24385020-22A8-4F84-A1AC-CA639F6F6565Q33615541-4362070D-D24E-437A-9B20-B8D0B76EDA02Q34588134-F527939A-77A7-4CA5-89AE-FC5B482902E5Q35028773-97BE27B6-C614-43AC-9C16-35219CD51453Q35161887-57378150-65E8-4DF2-BE68-72282D48DA08Q35227614-B9AFDCBF-9F55-4243-B7D9-690BF3E3C72DQ35756718-B065442A-4D03-4A4C-A4E3-5B56ABC8F67EQ35761594-4526FBBB-78F6-4693-9016-393EAB5E0606Q35926934-01650EE4-BBA8-409D-8B25-FC63C752CD55Q36108707-AEA5ABCB-9EEF-4083-A148-3B5B00066C34Q36172370-8F1186A7-64D8-4BEF-800A-959AD6FF2825Q36575261-BF9AD269-976B-48C8-95D0-41DEA98EE296Q36663998-FE1C6027-EF07-4261-831F-9A2DD045ED4BQ37118981-FB6E1824-E07F-4D70-9EC5-07B5DC764774Q37384616-DB853D40-BD45-45EC-93BB-15D830B6BDBEQ37876127-21C1B8AC-AA99-4F3F-AF5A-AA7F6DCDBDEFQ38167310-D527D929-CB4A-4A7E-B580-CD0D61FB207CQ38177288-D5EA23CE-A20C-4DE4-A5CB-D8A4B8E4853CQ42155688-25255CBA-CA3A-47D7-895E-21B32613C8ACQ42881016-F33184CE-56EB-476C-94E8-ECA6A0ECE368Q46169738-33786B9C-1C8A-4DFB-8F04-7E312509BDDDQ46587750-905D1E8F-8C11-409D-ACA5-03C5C08FB11AQ50246122-DB596D53-8117-408C-8473-F36A5FF26EE5
P2860
Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Internal limiting membrane pee ...... clusion: a report of 14 cases.
@ast
Internal limiting membrane pee ...... clusion: a report of 14 cases.
@en
type
label
Internal limiting membrane pee ...... clusion: a report of 14 cases.
@ast
Internal limiting membrane pee ...... clusion: a report of 14 cases.
@en
prefLabel
Internal limiting membrane pee ...... clusion: a report of 14 cases.
@ast
Internal limiting membrane pee ...... clusion: a report of 14 cases.
@en
P1433
P1476
Internal limiting membrane pee ...... clusion: a report of 14 cases.
@en
P2093
Mark S Mandelcorn
Ravi Krishna Nrusimhadevara
P304
P356
10.1097/00006982-200406000-00002
P577
2004-06-01T00:00:00Z